Synchrony Financial (SYF)
44.14 USD -1.04 (-2.30%) Volume: 5.35M
Synchrony Financial’s stock price currently sits at 44.14 USD, experiencing a dip of -2.30% this trading session with a volume of 5.35M. Despite this, SYF has shown a resilient annual performance with a year-to-date increase of +15.58%, showcasing its potential for growth and profitability in the financial market.
Latest developments on Synchrony Financial
Synchrony Financial stock experienced fluctuations this week as Apollon Wealth Management LLC acquired shares while National Bank of Canada FI and M&T Bank Corp sold off portions of their holdings. Despite releasing monthly credit statistics and a new study on hearing loss symptoms, the company underperformed compared to competitors. Analysts remain optimistic, with Boston Partners holding a significant stock position and expectations for strong Q2 2024 earnings. Amidst rising pressures on credit card issuers, Synchrony Financial continues to navigate market challenges.
A look at Synchrony Financial Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 5 | |
| Resilience | 5 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Synchrony Financial has a positive long-term outlook. With high scores in Growth, Resilience, and Momentum, the company is positioned for continued success in the consumer financial services industry. This indicates that Synchrony Financial is well-equipped to adapt to market changes, maintain strong performance, and capitalize on growth opportunities.
Synchrony Financial‘s Value and Dividend scores are also solid, further indicating the company’s stability and attractiveness for investors. Overall, Synchrony Financial‘s strong performance across multiple factors suggests a promising future for the company as it continues to provide credit products through various partnerships with retailers, merchants, manufacturers, and healthcare providers.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
